Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

  1. Sulkowski, M.S.
  2. Fessel, W.J.
  3. Lazzarin, A.
  4. Berenguer, J.
  5. Zakharova, N.
  6. Cheinquer, H.
  7. Côté, P.
  8. Dieterich, D.
  9. Gadano, A.
  10. Matthews, G.
  11. Molina, J.-M.
  12. Moreno, C.
  13. Pineda, J.A.
  14. Pulido, F.
  15. Rivero, A.
  16. Rockstroh, J.
  17. Hernandez, D.
  18. McPhee, F.
  19. Eley, T.
  20. Liu, Z.
  21. Mendez, P.
  22. Hughes, E.
  23. Noviello, S.
  24. Ackerman, P.
Journal:
Hepatology International

ISSN: 1936-0541 1936-0533

Year of publication: 2017

Volume: 11

Issue: 2

Pages: 188-198

Type: Article

DOI: 10.1007/S12072-017-9788-Z GOOGLE SCHOLAR

Sustainable development goals